Press release

JERUSALEM, JUNE 11, 2010 – OurCrowd, the world’s largest global venture investment platform will host the OurCrowd Pandemic Innovation Conference on June 22 to explore the latest technological solutions to the coronavirus crisis, including vaccination, treatment, diagnostics and prevention of the disease. Read more...

KIRYAT SHEMONA, ISRAEL – June 9, 2020 –  MigVax Corp., an Israeli company developing a vaccine for COVID-19 (MigVax-101), today announced the appointment of Eyal Desheh as chairman of its board of directors. Read more...

June 2, 2020 – JERUSALEM, Israel –  OurCrowd, the world’s largest crowdfunded-venture investment platform, today announced the launch of its Pandemic Innovation Fund. The Fund plans to raise $100 million for investment in urgent technological solutions for the medical, business, educational and social needs triggered by global pandemics and other health emergencies. Read more...

May 20, 2020 – JERUSALEM –  OurCrowd, the world’s largest crowdfunding venture investment platform, based in Jerusalem, today announced that the number of vacant positions at its portfolio companies has risen to 350, with 90 new job vacancies added since the start of April, 41 of them in Israel. Read more...

Kiryat Shemona, Israel, April 22, 2020 –  OurCrowd, the world’s largest crowdfunding venture investment platform, based in Jerusalem, today announced that it would lead a $12 million investment in the newly formed MigVax Corp., which will develop a novel COVID-19 vaccine. MigVax, an affiliate of The Migal Galilee Research Institute, is pioneering the effort to develop Israel’s human vaccine against COVID-19. Read more...